That’s good to hear tsuba, not only is it evidence of continuing Evolis products, potential profits from that segment but also presumably future Midkine royalties.
in turn of course the expected sp increase as the company renaissance progresses.
Ann: Appendix 4E and Preliminary Final Report, page-9
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.768M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $11.31K | 1.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1650000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 915710 | 1 |
View Market Depth
| Last trade - 14.23pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 14.3 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.6¢ | 287949 | ||
| Last updated 14.34pm 14/06/2024 ? | |||||
| AN1 (ASX) Chart |